Syndax Pharmaceuticals (SNDX) Short Interest Ratio & Short Volume $13.73 +0.10 (+0.73%) (As of 09:58 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Syndax Pharmaceuticals Short Interest DataSyndax Pharmaceuticals (SNDX) has a short interest of 14.40 million shares. This marks a 35.85% increase in short interest from the previous month. The short interest ratio (days to cover) is 9.7, indicating that it would take 9.7 days of the average trading volume of 1.21 million shares to cover all short positions.Current Short Interest14,400,000 sharesPrevious Short Interest10,600,000 sharesChange Vs. Previous Month+35.85%Dollar Volume Sold Short$240.77 millionShort Interest Ratio9.7 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares85,358,000 sharesPercentage of Shares Shorted16.87%Today's Trading Volume158,609 sharesAverage Trading Volume1,207,683 sharesToday's Volume Vs. Average13% Short Selling Syndax Pharmaceuticals? Sign up to receive the latest short interest report for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSNDX Short Interest Over TimeSNDX Days to Cover Over TimeSNDX Percentage of Float Shorted Over Time Ad Wealthpin ProVacuum up cash with these special trades? Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formula right here. Now, the most important thing is that this equation — when applied to certain tickers at a certain time each month —- can trigger these “volatility vacuums.” And when that happens, anyone has the shot at sucking out payouts of $290, $350, even $1,350 in as little as 24 hours. (With just a $1k starting stake!) Granted, there were smaller wins and those that did not work out but best of all, we can know exactly when these opportunities will hit. I’ve used this info to create a Cash Calendar that lays out the precise dates of these payouts. And I’m sending it for FREE to anyone who joins me during my FREE training right here. Syndax Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202414,400,000 shares $240.77 million +35.9%N/A9.7 $16.72 11/15/202410,600,000 shares $167.80 million -0.6%N/A7.7 $15.83 10/31/202410,660,000 shares $201.05 million +1.4%N/A11.2 $18.86 10/15/202410,510,000 shares $207.57 million +4.3%N/A10.7 $19.75 9/30/202410,080,000 shares $194.04 million +4.2%N/A10 $19.25 9/15/20249,670,000 shares $184.89 million +1.9%N/A9.2 $19.12 Get the Latest News and Ratings for SNDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20249,490,000 shares $195.02 million +0.6%N/A9 $20.55 8/15/20249,430,000 shares $188.22 million +9.8%N/A8.8 $19.96 7/31/20248,590,000 shares $194.99 million +0.8%N/A7.8 $22.70 7/15/20248,520,000 shares $207.72 million +2.2%N/A8.3 $24.38 6/30/20248,340,000 shares $171.22 million -15.9%N/A8.1 $20.53 6/15/20249,920,000 shares $199.49 million +2.8%N/A9.8 $20.11 5/31/20249,650,000 shares $185.96 million -3.8%N/A9.1 $19.27 5/15/202410,030,000 shares $220.06 million -0.8%N/A9.6 $21.94 4/30/202410,110,000 shares $213.62 million +5.3%N/A9.4 $21.13 4/15/20249,600,000 shares $207.55 million -0.2%N/A8.3 $21.62 3/31/20249,620,000 shares $228.96 million +15.5%N/A8.2 $23.80 3/15/20248,330,000 shares $195.92 million -8.4%N/A6.9 $23.52 2/29/20249,090,000 shares $213.07 million +5.7%N/A6.1 $23.44 2/15/20248,600,000 shares $194.96 million -1.0%N/A5.8 $22.67 1/31/20248,690,000 shares $178.06 million No ChangeN/A5.8 $20.49 1/15/20248,690,000 shares $193.27 million +3.7%N/A5.4 $22.24 12/31/20238,380,000 shares $181.09 million -19.0%N/A4.7 $21.61 12/15/202310,340,000 shares $214.76 million +1.1%N/A4.8 $20.77 11/30/202310,230,000 shares $170.28 million -3.7%N/A5.4 $16.65 11/15/202310,620,000 shares $159.94 million +6.4%N/A6.2 $15.06 10/31/20239,980,000 shares $140.52 million +17.4%N/A6.1 $14.08 10/15/20238,500,000 shares $101.92 million +12.1%N/A5.7 $11.99 9/30/20237,580,000 shares $110.06 million -0.1%N/A6 $14.52 9/15/20237,590,000 shares $131.76 million +9.1%N/A9.8 $17.36 8/31/20236,960,000 shares $128.83 million -2.8%N/A8.8 $18.51 8/15/20237,160,000 shares $132.03 million +7.7%N/A8.4 $18.44 7/31/20236,650,000 shares $141.78 million +12.1%N/A7.4 $21.32 7/15/20235,930,000 shares $125.42 million +3.3%N/A6.8 $21.15 6/30/20235,740,000 shares $120.14 million +2.5%N/A6.5 $20.93 6/15/20235,600,000 shares $119.45 million -10.0%N/A5.9 $21.33 5/31/20236,220,000 shares $124.21 million -2.7%N/A6.7 $19.97 5/15/20236,390,000 shares $135.15 million -2.0%N/A7.4 $21.15 4/30/20236,520,000 shares $133.99 million -5.2%N/A7.9 $20.55 4/15/20236,880,000 shares $137.60 million -9.8%N/A8.6 $20.00Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover 3/31/20237,630,000 shares $161.15 million +12.4%N/A9.5 $21.12 3/15/20236,790,000 shares $151.42 million +13.4%N/A8.9 $22.30 2/28/20235,990,000 shares $151.85 million +8.5%N/A7 $25.35 2/15/20235,520,000 shares $143.46 million +0.6%N/A6.8 $25.99 1/31/20235,490,000 shares $157.56 million +0.6%N/A6.5 $28.70 1/15/20235,460,000 shares $143.65 million -14.3%N/A6.4 $26.31 12/30/20226,370,000 shares $162.12 million +22.5%N/A7.3 $25.45 12/15/20225,200,000 shares $125.84 million +17.7%N/A6.1 $24.20 11/30/20224,420,000 shares $105.90 million +5.7%N/A5.8 $23.96 11/15/20224,180,000 shares $91.46 million +2.7%N/A6 $21.88 10/31/20224,070,000 shares $93.45 million -9.2%N/A5.9 $22.96 10/15/20224,480,000 shares $105.41 million +0.9%9.4%6.7 $23.53 9/30/20224,440,000 shares $106.69 million -3.5%9.3%6.7 $24.03 9/15/20224,600,000 shares $113.02 million No Change9.6%7.2 $24.57 8/31/20224,600,000 shares $108.61 million +0.4%9.7%7 $23.61 8/15/20224,580,000 shares $113.31 million +5.1%9.6%7.1 $24.74 7/31/20224,360,000 shares $88.81 million +2.6%9.2%6.6 $20.37 7/15/20224,250,000 shares $80.92 million -24.8%9.2%6.8 $19.04 6/30/20225,650,000 shares $108.71 million -4.2%12.3%9.6 $19.24 6/15/20225,900,000 shares $95.76 million -0.7%12.8%10 $16.23 5/31/20225,940,000 shares $98.01 million -6.5%13.0%10.4 $16.50 5/15/20226,350,000 shares $89.60 million -1.6%13.9%10.9 $14.11 4/30/20226,450,000 shares $108.17 million +5.9%14.3%11.5 $16.77 4/15/20226,090,000 shares $110.47 million +9.1%13.5%11.1 $18.14 3/31/20225,580,000 shares $96.98 million -9.6%12.3%10.1 $17.38 3/15/20226,170,000 shares $99.21 million +18.9%13.8%11.6 $16.08 2/28/20225,190,000 shares $80.91 million +5.3%12.2%8.7 $15.59 2/15/20224,930,000 shares $81.69 million +17.1%11.6%8.7 $16.57 1/31/20224,210,000 shares $68.79 million +25.3%10.0%7.7 $16.34 1/15/20223,360,000 shares $60.78 million No Change7.5%5.8 $18.09 12/31/20213,360,000 shares $73.55 million -5.4%N/A6 $21.89 12/15/20213,550,000 shares $67.34 million +12.0%8.0%5.8 $18.97 11/30/20213,170,000 shares $50.62 million -6.8%7.4%5.8 $15.97 11/15/20213,400,000 shares $60.83 million -45.8%8.0%6.3 $17.89 10/29/20216,270,000 shares $121.95 million -1.0%14.6%11.6 $19.45 10/15/20216,330,000 shares $117.67 million -9.1%14.7%13.1 $18.59 9/30/20216,960,000 shares $133.01 million -11.0%16.2%13.8 $19.11 9/15/20217,820,000 shares $151.40 million -5.2%18.2%15.7 $19.36 8/31/20218,250,000 shares $144.29 million +2.7%19.2%17.9 $17.49 8/13/20218,030,000 shares $127.76 million -2.0%18.8%17.5 $15.91 7/30/20218,190,000 shares $119.41 million -5.2%19.4%16.6 $14.58 7/15/20218,640,000 shares $133.06 million +10.1%20.5%14.7 $15.40 6/30/20217,850,000 shares $134.78 million +1.7%18.6%9.8 $17.17 6/15/20217,720,000 shares $147.84 million +2.5%18.3%9.4 $19.15 5/28/20217,530,000 shares $138.33 million +3.9%17.9%8.8 $18.37 5/14/20217,250,000 shares $131.30 million -1.2%N/A7.7 $18.11 4/30/20217,340,000 shares $117.07 million +16.3%N/A7.9 $15.95 4/15/20216,310,000 shares $136.80 million -7.1%N/A7 $21.68 3/31/20216,790,000 shares $142.32 million +27.9%N/A10.1 $20.96 3/15/20215,310,000 shares $121.65 million +7.7%N/A7.4 $22.91Could this be the hottest crypto discovery of all time? (Ad)I want to let you in on what may be the hottest crypto discovery of all time… One that has NOTHING to do with creating a crypto wallet or touching ANY risky coin for that matter. Instead, it’s a way that could let regular folks like you and me target 10X the possible results you’d expect from buying Bitcoin … in just a fraction of the time It sounds nuts… trust me I know that… But just as I would hate for you to jump into any risky crypto asset… That’s exactly how I would hate for you to miss out on what could be a safer and better way to benefit from the crypto bull run of 2024. Which is why I’m giving you an opportunity to get all the details of this iconic crypto discovery with you for the first time ever… completely free…If you want in, Just Click Here 2/26/20214,930,000 shares $114.82 million No ChangeN/A7 $23.29 2/12/20214,930,000 shares $103.83 million +2.1%N/A7.5 $21.06 1/29/20214,830,000 shares $97.32 million -10.2%N/A7.1 $20.15 1/15/20215,380,000 shares $130.63 million -2.5%N/A7.3 $24.28 12/31/20205,520,000 shares $126.13 million +15.7%N/A7.7 $22.85 12/15/20204,770,000 shares $121.06 million +5.3%N/A7 $25.38 11/30/20204,530,000 shares $103.60 million -1.5%N/A7.3 $22.87 11/15/20204,600,000 shares $96.60 million +5.0%N/A9 $21.00 10/30/20204,380,000 shares $79.02 million -4.8%N/A9.3 $18.04 10/15/20204,600,000 shares $73.42 million +2.5%N/A12.6 $15.96 9/30/20204,490,000 shares $66.27 million +23.0%N/A14.8 $14.76 9/15/20203,650,000 shares $63.80 million +1.7%N/A11.3 $17.48 8/31/20203,590,000 shares $58.55 million +1.4%N/A11.4 $16.31 8/14/20203,540,000 shares $56.04 million +3.5%N/A9.1 $15.83 7/31/20203,420,000 shares $48.26 million -4.7%N/A5.9 $14.11 7/15/20203,590,000 shares $51.91 million -6.0%N/A3.9 $14.46 6/30/20203,820,000 shares $55.24 million +18.6%N/A4.2 $14.46 6/15/20203,220,000 shares $49.91 million +11.4%N/A3.7 $15.50 5/29/20202,890,000 shares $46.82 million +28.4%11.4%3.4 $16.20 5/15/20202,250,000 shares $41.67 million +27.8%8.8%2.8 $18.52 4/30/20201,760,000 shares $31.68 million -0.6%7.8%3 $18.00 4/15/20201,770,000 shares $19.29 million -1.7%7.8%6.8 $10.90 3/31/20201,800,000 shares $21.06 million +49.1%8.0%7.1 $11.70 3/13/20201,207,200 shares $12.24 million +34.7%5.4%4.4 $10.14 2/28/2020896,300 shares $8.17 million +6.4%4.0%4.3 $9.11 2/14/2020842,100 shares $10.00 million +21.8%3.9%4.6 $11.87 1/31/2020691,300 shares $7.49 million +13.4%3.0%4.1 $10.84 1/15/2020609,700 shares $5.65 million +0.5%3.0%5.4 $9.26 12/31/2019606,500 shares $4.27 million +2.0%3.0%5 $7.04 SNDX Short Interest - Frequently Asked Questions What is Syndax Pharmaceuticals' current short interest? Short interest is the volume of Syndax Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 14,400,000 shares of SNDX short. Learn More on Syndax Pharmaceuticals' current short interest. What is a good short interest ratio for Syndax Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNDX shares currently have a short interest ratio of 10.0. Learn More on Syndax Pharmaceuticals's short interest ratio. Which institutional investors are shorting Syndax Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Syndax Pharmaceuticals: Jane Street Group LLC, and Wolverine Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Syndax Pharmaceuticals' short interest increasing or decreasing? Syndax Pharmaceuticals saw a increase in short interest in November. As of November 30th, there was short interest totaling 14,400,000 shares, an increase of 35.8% from the previous total of 10,600,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Syndax Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Syndax Pharmaceuticals: Arcellx, Inc. (12.85%), ADMA Biologics, Inc. (5.46%), Apellis Pharmaceuticals, Inc. (17.53%), Ultragenyx Pharmaceutical Inc. (3.66%), Biohaven Ltd. (7.75%), Immunovant, Inc. (20.39%), Avidity Biosciences, Inc. (12.52%), Scholar Rock Holding Co. (15.76%), Organon & Co. (5.32%), PTC Therapeutics, Inc. (5.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Syndax Pharmaceuticals stock? Short selling SNDX is an investing strategy that aims to generate trading profit from Syndax Pharmaceuticals as its price is falling. SNDX shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Syndax Pharmaceuticals? A short squeeze for Syndax Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNDX, which in turn drives the price of the stock up even further. How often is Syndax Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNDX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies ACLX Short Squeeze ADMA Short Squeeze APLS Short Squeeze RARE Short Squeeze BHVN Short Squeeze IMVT Short Squeeze RNA Short Squeeze SRRK Short Squeeze OGN Short Squeeze PTCT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNDX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syndax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syndax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
